Mark Sabag

2018

In 2018, Mark Sabag earned a total compensation of $5.2M as Executive Vice President, Global Human Resources at Teva Pharmaceutical Industries, a 108% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,090,467
Option Awards$866,685
Salary$605,749
Stock Awards$2,254,711
Other$427,724
Total$5,245,336

Sabag received $2.3M in stock awards, accounting for 43% of the total pay in 2018.

Sabag also received $1.1M in non-equity incentive plan, $866.7K in option awards, $605.7K in salary and $427.7K in other compensation.

Rankings

In 2018, Mark Sabag's compensation ranked 1,891st out of 14,244 executives tracked by ExecPay. In other words, Sabag earned more than 86.7% of executives.

ClassificationRankingPercentile
All
1,891
out of 14,244
87th
Division
Manufacturing
678
out of 5,758
88th
Major group
Chemicals And Allied Products
223
out of 2,119
90th
Industry group
Drugs
176
out of 1,808
90th
Industry
Pharmaceutical Preparations
134
out of 1,382
90th
Source: SEC filing on April 16, 2019.

Sabag's colleagues

We found four more compensation records of executives who worked with Mark Sabag at Teva Pharmaceutical Industries in 2018.

2018

Kåre Schultz

Teva Pharmaceutical Industries

Chief Executive Officer

2018

Carlo de Notaristefani

Teva Pharmaceutical Industries

Executive Vice President, Global Operations

2018

Hafrun Fridriksdottir

Teva Pharmaceutical Industries

Executive Vice President, Global Research and Development

2018

Michael McClellan

Teva Pharmaceutical Industries

Chief Financial Officer

News

You may also like